Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the effect of autologous platelet-rich plasma (PRP) in the treatment of mild to moderate eyebrow hypotrichosis. This is a randomized clinical trial to evaluate the effect of autologous platelet rich plasma in subjects with mild to moderate eyebrow hypotrichosis. Approximately 40 subjects will be randomized to receive platelet-rich plasma (PRP) or saline injections. The study is designed as an 9-month study. This study was a pilot study designed to determine feasibility of this procedure. Subjects currently living in the Chicago metropolitan area and meet inclusion/exclusion criteria will be considered for enrollment.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04018859
Study type Interventional
Source Northwestern University
Contact Alejandra Onate, M.S.
Phone 312-503-5944
Email onate@northwestern.edu
Status Recruiting
Phase Phase 2
Start date September 25, 2019
Completion date December 2024

See also
  Status Clinical Trial Phase
Completed NCT01765764 - Bimatoprost for the Treatment of Eyebrow Hypotrichosis Phase 3
Completed NCT01924000 - Minoxidil 1% for Eyebrow Enhancement Phase 4